VEGFC Antikörper (AA 112-227)
-
- Target Alle VEGFC Antikörper anzeigen
- VEGFC (Vascular Endothelial Growth Factor C (VEGFC))
-
Bindungsspezifität
- AA 112-227
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VEGFC Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Vascular endothelial growth factor C protein (112-227AA)
- Isotyp
- IgG
- Top Product
- Discover our top product VEGFC Primärantikörper
-
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 108-223) antibody
VEGFC Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 321-415) antibodyVEGFC Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 20-49), (N-Term) antibodyVEGFC Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB11713 unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 20-49) antibodyVEGFC Reaktivität: Human WB, ELISA, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 108-223) antibodyVEGFC Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 248-277) antibodyVEGFC Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB11715 unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (C-Term), (N-Term) antibodyVEGFC Reaktivität: Human, Maus WB Wirt: Maus Monoclonal 30AT1174-77 unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 1-290) antibodyVEGFC Reaktivität: Human WB, IHC, IHC (p) Wirt: Maus Monoclonal unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 47-413) antibodyVEGFC Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor C (VEGFC) (AA 27-57), (N-Term) antibodyVEGFC Reaktivität: Human WB, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- VEGFC (Vascular Endothelial Growth Factor C (VEGFC))
- Andere Bezeichnung
- VEGFC (VEGFC Produkte)
- Synonyme
- VEGFC antikoerper, vegf-c antikoerper, xvegf-c antikoerper, Flt4-L antikoerper, VRP antikoerper, AW228853 antikoerper, VEGF-C antikoerper, vascular endothelial growth factor c antikoerper, vascular endothelial growth factor C antikoerper, vascular endothelial growth factor C S homeolog antikoerper, vegfc antikoerper, VEGFC antikoerper, vegfc.S antikoerper, Vegfc antikoerper
- Hintergrund
-
Background: Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
Aliases: Flt 4L antibody, Flt4 ligand antibody, FLT4 ligand DHM antibody, Flt4-L antibody, Flt4L antibody, Vascular endothelial growth factor C antibody, Vascular endothelial growth factor related protein antibody, Vascular endothelial growth factor-related protein antibody, VEGF C antibody, VEGF-C antibody, Vegfc antibody, VEGFC_HUMAN antibody, VRP antibody
- UniProt
- P49767
- Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2
-
